Bilbao‐Asensio, M., Ruiz‐de‐Angulo, A., Arguinzoniz, A. G., Cronin, J., Llop, J., Zabaleta, A., . . . Mareque‐Rivas, J. C. (2023). Redox‐Triggered Nanomedicine via Lymphatic Delivery: Inhibition of Melanoma Growth by Ferroptosis Enhancement and a Pt(IV)‐Prodrug Chemoimmunotherapy Approach. Advanced therapeutics, 6(2), 1. https://doi.org/10.1002/adtp.202200179
Chicago Style (17th ed.) CitationBilbao‐Asensio, Marc, et al. "Redox‐Triggered Nanomedicine via Lymphatic Delivery: Inhibition of Melanoma Growth by Ferroptosis Enhancement and a Pt(IV)‐Prodrug Chemoimmunotherapy Approach." Advanced Therapeutics 6, no. 2 (2023): 1. https://doi.org/10.1002/adtp.202200179.
MLA (9th ed.) CitationBilbao‐Asensio, Marc, et al. "Redox‐Triggered Nanomedicine via Lymphatic Delivery: Inhibition of Melanoma Growth by Ferroptosis Enhancement and a Pt(IV)‐Prodrug Chemoimmunotherapy Approach." Advanced Therapeutics, vol. 6, no. 2, 2023, p. 1, https://doi.org/10.1002/adtp.202200179.